New York, NY, United States
New York, NY, United States

Time filter

Source Type

MINNEAPOLIS, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that it has agreed to grant GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in Poland and certain other countries in Central Europe.  This builds upon a previously announced arrangement granting GLG exclusive rights to market and distribute STREAMWAY in the U.K. and an initial agreement to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures. GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,800 operating rooms in Poland.  Marketing is expected to begin immediately upon receipt of the CE Mark and will be managed from GLG’s facility in Gdansk, Poland. The agreement will also include the Czech Republic, Latvia, Estonia and Lithuania, with sales activities expected to begin in those countries soon after the introduction in Poland. Skyline applied for CE Mark approval to market STREAMWAY in the European Union and certain other countries in July 2016, following receipt of ISO 13485:2003 certification. “We are excited to further solidify and expand our relationship with Skyline Medical with this expansion of our exclusive sales and marketing territory, the second agreement we have we have announced this week,” said Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma. “Central Europe is expected to be a very attractive market for STREAMWAY System sales, orchestrated by our general manager in Poland.  We currently have pharmaceutical and diagnostic development laboratories in Poland, which are supported by grants from the Polish government. The STREAMWAY System will make an excellent addition to our portfolio of products in development.” In June 2016 STREAMWAY received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices that is awarded when an organization demonstrates its ability to provide medical devices and related services that consistently meet customer and regulatory requirements applicable to medical devices and related services, and is a requirement for medical device clearance in Canada, the EU and a majority of other countries that require products meet EU safety, health and environmental requirements. Under the terms of an agreement announced in September 2016, GLG intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures.  Initial tests are anticipated to include cancer biomarkers and infectious diseases.  The oncology test panels will feature GLG's patented inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3), which are in preclinical development for a new generation of targeted therapies. About GLG, LLC. Founded in 2009 and located in Jupiter, Fla., GLG Pharma, LLC is a privately held, early stage, biotechnology company developing personalized therapies for patients with cancer and other proliferative diseases. GLG Pharma’s therapeutics are expected to aid in the treatment of a wide variety of cancers and address unmet needs in the multi-billion dollar anti-cancer market with potentially greater efficacy and fewer side effects than existing therapies. For more information on GLG Pharma visit: http://www.glgpharma.com. About the STREAMWAY System Skyline Medical's revolutionary, FDA-cleared STREAMWAY System is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids, and minimizes human intervention for better safety while improving compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. It also provides unlimited capacity for increased efficiency in the operating room, which leads to greater profitability. The STREAMWAY eliminates canisters to reduce overhead costs and provides greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the U.S. About Skyline Medical Inc. Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com. Forward-looking Statements: Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions;  the potential delisting of the Company’s common stock on The Nasdaq Capital Market as a result of the Company’s failures to comply with listing standards, in which case the liquidity of our common stock would likely be impaired and there would likely be a reduction in our coverage by security analysts and the news media, thereby resulting in lower prices for our common stock than might otherwise prevail; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology, including the possibility that the development of applicable technologies by GLG Pharma, LLC will be delayed, will not occur or will not receive applicable regulatory approvals on a timely basis; the Company’s ability to consummate its joint venture with Electronic On-Ramp, Inc.; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov.  This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.


MINNEAPOLIS, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a distribution agreement granting GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in the U.K. Under the terms of the agreement, GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,600 operating rooms in the U.K.  Marketing is expected to begin immediately upon receipt of the CE Mark.  Skyline applied for CE Mark approval to market STREAMWAY in the European Union and certain other countries in July 2016, following receipt of ISO 13485:2003 certification. “We look forward to bringing the benefits of the STREAMWAY System to healthcare professionals and facilities across the U.K. and to an even closer relationship with Skyline,” said Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma. “We have considerable experience with bringing medical products to EU facilities, which will be invaluable to our work with the STREAMWAY System,” Mr. Gabriel added. In June 2016 STREAMWAY received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices that is awarded when an organization demonstrates its ability to provide medical devices and related services that consistently meet customer and regulatory requirements applicable to medical devices and related services, and is a requirement for medical device clearance in Canada, the EU and a majority of other countries that require products meet EU safety, health and environmental requirements. Under the terms of an agreement announced in September 2016, GLG intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures.  Initial tests are anticipated to include cancer biomarkers and infectious diseases.  The oncology test panels will feature GLG's patented inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3), which are in preclinical development for a new generation of targeted therapies. About GLG, LLC. Founded in 2009 and located in Jupiter, Fla., GLG Pharma, LLC is a privately held, early stage, biotechnology company developing personalized therapies for patients with cancer and other proliferative diseases. GLG Pharma’s therapeutics are expected to aid in the treatment of a wide variety of cancers and address unmet needs in the multi-billion dollar anti-cancer market with potentially greater efficacy and fewer side effects than existing therapies. For more information on GLG Pharma visit: http://www.glgpharma.com. About the STREAMWAY System Skyline Medical's revolutionary, FDA-cleared STREAMWAY System is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids, and minimizes human intervention for better safety while improving compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. It also provides unlimited capacity for increased efficiency in the operating room, which leads to greater profitability. The STREAMWAY eliminates canisters to reduce overhead costs and provides greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the U.S. About Skyline Medical Inc. Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com. Forward-looking Statements: Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions;  the potential delisting of the Company’s common stock on The Nasdaq Capital Market as a result of the Company’s failures to comply with listing standards, in which case the liquidity of our common stock would likely be impaired and there would likely be a reduction in our coverage by security analysts and the news media, thereby resulting in lower prices for our common stock than might otherwise prevail; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology, including the possibility that the development of applicable technologies by GLG Pharma, LLC will be delayed, will not occur or will not receive applicable regulatory approvals on a timely basis; the Company’s ability to consummate its joint venture with Electronic On-Ramp, Inc.; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov.  This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.


NEW YORK, Feb. 22, 2017 /PRNewswire/ -- GLG (Gerson Lehrman Group, Inc.) today launched its latest video series, Anatomy of a Decision, featuring key leaders discussing how they have made some of their toughest decisions over the course of their careers. The series' first edition...


News Article | October 28, 2015
Site: www.marketwired.com

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 28, 2015) - The Canadian Beverage Association ("CBA") has established a new initiative to reduce caloric intake from non-alcoholic beverages by 20% over the next ten years. The CBA described this initiative as "a substantial and unique voluntary effort by an industry to help fight obesity" and expects that it "will transform the beverage landscape in Canada." The initiative includes a commitment "to provid[e] consumers with more low- and no-calorie choices." GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, applauds the CBA's health-oriented focus and its firm commitment to reducing caloric intake among Canadian consumers. GLG has proven natural zero-calorie sweetener solutions already in use in global beverage applications that have successfully reduced calories by 20% and at significantly higher levels. As a proud Canadian company, we are looking forward to working with CBA members in reaching their calorie reduction goals. GLG's natural product portfolio includes zero-calorie stevia and monk fruit extracts, proprietary blends and other functional natural ingredients. GLG also has extensive beverage formulation experience and is ready to demonstrate its expertise to the CBA and constituent companies in developing both low- and no-calorie beverages. GLG Life Tech Corporation is a global leader in the supply of high-purity zero calorie natural sweeteners including stevia and monk fruit extracts used in food and beverages. GLG's vertically integrated operations, which incorporate our Fairness to Farmers program and emphasize sustainability throughout, cover each step in the stevia and monk fruit supply chains including non-GMO seed and seedling breeding, natural propagation, growth and harvest, proprietary extraction and refining, marketing and distribution of the finished products. Additionally, to further meet the varied needs of the food and beverage industry, GLG has launched its Naturals+ product line, enabling it to supply a host of complementary ingredients reliably sourced through its supplier network in China. For further information, please visit www.glglifetech.com. Forward-looking statements: This press release may contain certain information that may constitute "forward-looking statements" and "forward looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or words and phrases that state or indicate that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. While the Company has based these forward-looking statements on its current expectations about future events, the statements are not guarantees of the Company's future performance and are subject to risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Such factors include amongst others the effects of general economic conditions, consumer demand for our products and new orders from our customers and distributors, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations, industry supply levels, competitive pricing pressures and misjudgments in the course of preparing forward-looking statements. Specific reference is made to the risks set forth under the heading "Risk Factors" in the Company's Annual Information Form for the financial year ended December 31, 2013. In light of these factors, the forward-looking events discussed in this press release might not occur. Further, although the Company has attempted to identify factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. As there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements, readers should not place undue reliance on forward-looking statements.


News Article | February 3, 2015
Site: www.fastcompany.com

Sometimes building a new headquarters is especially difficult. When my company, a global 1,000-person professional learning platform called GLG, was in the middle of our pivot, we felt our new office could help define our future, but we had two unexciting options. One option was traditional private offices and cubicles, which are unimaginative and restrictive. The other was an open office plan—the shiny new toy in office design 15 years ago—but a growing body of evidence suggests it decreases productivity and weakens job performance. Instead we designed our new corporate headquarters across the street from Grand Central Terminal—65,000 square feet over two floors for nearly 300 New York employees—around a new paradigm, neither open nor full of private offices. Our architect, Clive Wilkinson, introduced us to an idea called activity-based working (ABW). The thesis is that people should work in the type of space that supports the work they’re actually doing, and that might change many times throughout a day. ABW suits my firm particularly well. We bring together top professionals to learn from each other and in the process make it easier to share the knowledge they need to stay innovative. There are four reasons ABW is just the right layout for our workplace and could be for yours, too. No one has an assigned desk or office, including me. The idea, again, is that one kind of workspace—more specifically one desk in one location—does not suit all types of work equally. We have a menu of options that people can use for different projects throughout the day. We have large open space surrounded by private meeting rooms of different sizes. We have "neighborhoods" where people can work with their teams. Each contains team tables with individual workstations, enclosed glass meeting pods, chairs of different shapes and sizes, and adjustable standing desks. Some people excel in energetic environments filled with interactions. Some work best alone. Others only need a computer, and some spread out with papers. Everyone here has the freedom to decide how and where to work. Each morning we pick up our stuff from private lockers and choose a spot. We move around depending on the work that arises. There’s plenty of private space for confidential calls or reflection. At the end of the day, stuff goes back into our lockers. Yes, we give up our personal desks, but we gain the whole office. Trust and empowerment informed our design process. Early on we formed a design committee with representatives from each business unit and different areas of expertise. They worked closely with our designers. Their input made for a better office and their buy-in made for a smoother transition. Before the move, we surveyed our employees to understand their current work habits and expectations. After the move, we surveyed them again. The survey validated the benefits of our approach: two-thirds of our employees report using multiple workspaces, and 91% say they’re excited about the flexibility ABW affords. No one at GLG has a landline or desktop computer. Everyone uses laptops that dock at screens wherever we work. The physical telephone has been replaced with software phones that run on laptops with headsets. Our technology allows us to be flexible and mobile throughout the office. We didn’t get all the technology right at first. Our employee survey showed meeting room technology needed to be seamless and wasn’t. Armed with that feedback, we fashioned solutions to improve the user experience dramatically. Our growing pains underscore both the importance and the challenge of integrating good technology in the modern office from the beginning. Businesses benefit when folks from different departments, backgrounds, and roles share their ideas. Office design should encourage circulation and interaction, but also support individual focus when it is needed. No assigned desks is a start, and we still have a number of tables in a designated "quiet area." Our café has long tables for meals and other gatherings, as well as smaller tables for groups of different sizes to collaborate. It is a communal space. Overall, we have more seats than people, preparing us for considerable growth. In our survey, 98% of employees observe extensive support for collaboration in the new office. And since the move, dissatisfaction with the level of cooperation between teams fell from 25% to 13%. The survey also showed near unanimous enthusiasm for the way the new office facilitates diverse experiences and interactions: one-on-one or group meetings, catch-ups, private conversations, and creative brainstorming. We’ve been in our new space for six months. Already 80% of employees say the new style of working here makes them feel better about their jobs; 92% say it’s even fun. And having happier people translates into better work for our clients. So today the choice should not be between open offices and private spaces. A better alternative exists. What matters is that each worker has the kind of varied space for their personal working style and the work at hand. That office can be realized by embracing these elements: flexibility and variety, trust and empowerment, integrated technology, and collaboration and cross-pollination. This model of working can help businesses of all kinds become more creative, collaborative, and effective. —Alexander Saint-Amand is CEO of GLG, the world’s leading platform for professional learning and expertise.


GLG Insurance Professionals is proud to announce that it has decided to include coverage for specialty commercial vehicle insurance, enabling individual and fleet owners to obtain the kind of protection they need for their unique business interests. Commercial vehicles with specialized bodies and equipment need coverage that can protect unusual circumstances. Examples of specialized vehicles include fire trucks, ambulances, refuse vehicles, recycling trucks, refrigerated trailers, dry freight haulers, and vehicles with attached components, such as plows. "We understand that all trucks need specialized insurance covered that is tailored to the individualized needs of their particular type of vehicle," stated one of the representatives of the company. "Not only does your equipment need to be in top condition, but so does your insurance coverage. If you don't have the right kind of policy coverage, then you are placing your business at risk. We are here to make sure that doesn't happen." Individual and fleet owners of specialty vehicles are invited to visit the company's website (http://glgins.com/) for more information regarding this type of insurance coverage. GLG's dedicated specialty commercial vehicles insurance department is available to answer all questions related to this type of coverage. The staff at this department can assist clients in completing initial signups, setting up flexible payments, and initiating claim filings throughout the lifetime of the policy. GLG Insurance Professionals, a leading provider of insurance coverage located in the Las Vegas area, offers an all-inclusive selection for personal and business purposes, including the provision of specialty commercial vehicle insurance. Simplifying the selection of insurance products for their clientele, the staff at GLG Insurance offers free assistance to individuals looking for a more personalized experience when comparing the insurance options available to them. The company's website provides a wealth of information offering details on currently available insurance products for commercial vehicles. Visitors to the site can also request a free quote for a product tailored to their needs.


News Article | July 29, 2015
Site: www.builtinchicago.org

Chicago was just named one of the best startup ecosystems in the world, and when companies like G2 Crowd call the Second City home, it’s not hard to see why. The company, which provides the leading reviewing platform for enterprise software, announced it has nabbed a $7 million Series A round, bringing its total funding to right around $12 million. Pritzker Group Venture Capital led the round, with returning investors Chicago Ventures, Hyde Park Venture Partners, G2 Crowd Chairman Godard Abel and its management team all joining in. Participation also included industry leaders like GLG founder Thomas Lehrman and ExactTarget co-founder and CEO Scott Dorsey. “By bringing the collective power of trusted peers to the forefront, business buyers now have transparency when evaluating B2B software technologies,” said Tim Handorf, G2 Crowd’s co-founder and president in a statement. “We’re excited to use this investment to scale our platform, add more software categories with compelling reviews, and grow our awareness in the world of business software.” The company plans on using the funding to hire rockstar talent in order to accelerate growth and expand its community, which currently features more than 37,000 comprehensive user reviews for entire catalogues of business software. According to G2 Crowd, those reviews are read by 300,000 users on the prowl for business software — each and every month. The company has already begun adding key leadership members to its team. Earlier this year, they brought on former LinkedIn executive Adrienne Weissman as Chief Marketing Officer. Alongside the recent round of funding, Pritzker Group Venture Capital partner Adam Koopersmith will join the G2 Crowd board. “G2 Crowd is rapidly becoming the key information source for any executive in the purchasing review phase of B2B software technologies,” Koopersmith said in a statement. “We’re very impressed by the company’s rapid growth and we’re looking forward to partnering with the company’s leadership team to help G2 Crowd scale and further drive awareness of the industry’s increasing demand for expert peer advice.” G2 Crowd’s peer-reviewed, real-time insights are poised to disrupt a system that once relied solely on the outdated and out-of-touch opinions of software analysts to inform purchases. Have a tip for us or know of a company that deserves coverage? Email us via tips@builtin.com


News Article | April 27, 2015
Site: www.newyorker.com

Twenty years ago, when I was working as a White House special assistant in Bill Clinton’s public-liaison office, one of my jobs was to rally support for the President’s initiatives. We often focussed on enlisting business leaders, among whom the President had many supporters, thanks in part to the country’s robust economy. When I tried, however, to get C.E.O.s to endorse Clinton’s gay-rights initiatives, which included expanding protections against employment discrimination and hate crimes, as well as appointing gays to positions requiring confirmation by the U.S. Senate, I got very few takers. Just getting executives to a meeting about gay rights was a challenge, even though they generally liked being invited to the White House. I remember one event, in particular, for which the best we could do was get a producer, who was gay himself, to represent the business community. The entertainment industry was, at the time, the only business that wanted anything to do with gay rights. I was thinking about that era as I read the amicus brief submitted to the Supreme Court in support of marriage equality by three hundred and seventy-nine major businesses and business organizations, in connection with four landmark cases that will be argued before the Court on Tuesday. The brief has been signed by a broad cross-section of American businesses from every region of the country, reflecting the commitment to the issue that has evolved, at first slowly and then forcefully, over the past decade. The brief argues that laws restricting marriage to heterosexual couples “impose a significant burden on us and harm our ability to attract and retain the best employees.” Also recently, we saw companies rally in opposition to a so-called religious freedom law in Indiana, which would permit businesses to discriminate against the L.G.B.T. community under certain circumstances, based on religious beliefs. While that wasn’t the first time that this kind of support has been offered—last year, Jan Brewer, who was then Arizona’s governor, vetoed a similar measure after the business community objected—corporate leaders have never seemed as unified in opposition as they did in Indiana. On Twitter, Salesforce C.E.O. Marc Benioff wrote, “Today we are canceling all programs that require our customers/employees to travel to Indiana to face discrimination.” Angie’s List C.E.O. Bill Oesterle halted a planned forty-million-dollar expansion of his company’s headquarters, in Indianapolis, saying, “We believe that the impacts of that bill on our ability to hire and continue to build a high-growth technology company are material and are inconsistent with the state’s activities to encourage growth.” (Oesterle has since stepped down and announced his aim to become more involved in Indiana state politics.) And Marriott C.E.O. Arne Sorenson called the legislation “pure idiocy from a business perspective.” The reaction from the business world was considered by many observers to be the primary factor in getting the law revised. Companies now realize that, beyond the imperative to support human rights, it’s also smart business to be in favor of L.G.B.T. equality. This view may have started in Hollywood, but a number of other companies and leaders were also agents of change early on. Technology companies like Apple, Google, and Facebook not only enacted internal employee non-discrimination policies, they often publicly campaigned for gay rights. Apple, for its part, sanctioned gay employee groups as early as 1986. Ten years later, I.B.M. became the largest employer to extend health-care coverage to same-sex couples. A number of gay entrepreneurs who made a fortune in technology became full-time philanthropists and activists focussed on gay rights, such as Tim Gill of the Gill Foundation. The shift in corporate values has been apparent in other sectors of the U.S. economy, too, including at America’s biggest retailer, Walmart. In 2008, the company had adopted some gay-friendly policies, but Mike Duke, then its C.E.O., still felt that it was acceptable for him to sign a petition to ban gay adoption in Arkansas. (The subsequent ballot measure passed, though it was later struck down.) Five years after that, Walmart began to provide company-wide health-insurance benefits for the domestic partners of its workers, a move that included same-sex couples. And then last month, Walmart C.E.O. Doug McMillon issued a statement expressing his opposition to the discriminatory Indiana legislation. “Every day, in our stores,” he wrote, “we see firsthand the benefits diversity and inclusion have on our associates, customers and communities we serve.” Wall Street has also become a major public force for gay rights. In 2011, a large group of high-profile leaders signed an open letter urging New York State lawmakers to legalize same-sex marriage. The next year, Goldman Sachs C.E.O. Lloyd Blankfein, who had signed the letter, released a widely shared video ad, in which he offered a simple and clear message: “I’m Lloyd Blankfein, chairman and C.E.O. of Goldman Sachs, and I support marriage equality.” There have been exceptions, in recent years, to the wave of corporate support, especially in cases where money was involved. When Russian President Vladimir Putin issued a ban on gay “propaganda” during the 2014 Sochi Olympics, most Olympic sponsors looked the other way. (I wrote about that here.) Gay-rights groups organized protests and attempted to start boycotts of some brands, but to little or no effect. A few companies were willing to say something—A.T. & T., a sponsor of the U.S. Olympic team, became the first Olympic brand to condemn Russian policy (though it did not alter its participation), while Google tacitly registered its objection by creating a version of its search-page logo depicting athletes against a rainbow backdrop. Many others kept silent. The larger arc, though, has been toward support for equality. For more than a decade, the Human Rights Campaign has published a Corporate Equality Index, which rates major companies on pro-L.G.B.T. policies. When it was first introduced, in 2002, only thirteen companies achieved perfect scores, of three hundred and nineteen surveyed. Today, even though the index has been revised to make it more stringent, three hundred and sixty-six of seven hundred and eighty-one businesses scored a hundred per cent, including fourteen of the top twenty on Fortune’s rankings of the largest companies in the U.S. These companies are also coming together to discuss the issues and the politics involved in this larger shift. Last week, in New York, for example, some of America’s leading law firms and banks sponsored two days of presentations organized by Out Leadership, a professional network focussed on L.G.B.T. rights; later this week, in Los Angeles, the Milken Institute Global Conference will put on a panel entitled “How American Business Is Shaping the Gay Rights Debate.” (I moderated a panel at the first event, and will participate in the upcoming one; my company, GLG, was a sponsor of both events.) Which raises the question: Did business lead this revolution, or was it mostly reacting to and reflecting changes in public opinion? Much like the changes we have seen in the views of elected leaders—the very public evolution on the issue professed by Barack Obama, for example—the answer is, probably a little bit of both. No doubt business leaders have seen the evidence favoring the current movement, which suggests a certain level of self-interest. The Williams Institute, a think tank at U.C.L.A. law school, analyzed the existing research and found that “LGBT-supportive policies and workplace climates are linked to greater job commitment, improved workplace relationships, increased job satisfaction, and improved health outcomes among LGBT employees.” But business practices help both to define and to reflect our values. On L.G.B.T. rights, companies can play an important leading role. To be sure, the brief submitted by business leaders to the Supreme Court will be important to the Justices when the four same-sex-marriage cases are argued on Tuesday, and as they debate their ruling, which is expected in late June. Much remains to be done, especially outside the United States, where large multinational companies can play a potentially life-saving role in parts of Africa and the Middle East, especially, where some countries have laws that include draconian criminal penalties and even a death sentence for a range of actions associated with being L.G.B.T. There can be no mistake, though: companies have helped to spur a rapid evolution in public opinion in the U.S., with a majority of Americans now supporting not only marriage equality but also laws to prevent discrimination against gay people. When I was done reading the business brief for marriage, I e-mailed the Academy Award–winning film producer Bruce Cohen, who attended that meeting at the White House twenty years ago. “We are now winning in the court of public opinion as well,” Cohen wrote in his reply. “The business community sees this. And one thing is for sure—when a stand on an issue starts hurting your business instead of helping it, a lot of businesses come around.”


News Article | February 27, 2015
Site: www.bloombergview.com

Today’s discussion is aimed at the individual investor, though certainly the professionals might take something from our philosophical musings this morning. The bull market that dates to March 2009 is now entering one of its more interesting -- and perhaps dangerous -- phases. Not hazardous, mind you, from a market perspective, but from a behavioral one. Mr. Market will do what he is going to do, and that is unknown and unpredictable. However, what isn't unknown and is very predictable is that YOU are going to do something very foolish and self-destructive. The only variable is whether you are going to do this sooner rather than later. The noise box in your den (and on the wall of your trading room) has been tallying a catalog of potential crises and hazards. That parade of terribles seems to be getting longer each day. Although none of them are new, it is as if all of them have suddenly risen in unison, a chorus of noise, funk and angst. Markets are expensive, the Federal Reserve's stimulus of quantitative easing and zero interest rates is ending, the euro is collapsing, deflation is a threat, rates are rising, residential real estate is a mess, biotech is a bubble, oil prices are plunging, Grexit will arrive any day. Forty years of darkness! Earthquakes, volcanoes...The dead rising from the grave! Human sacrifice, dogs and cats living together...mass hysteria! OK, I got carried away. But for the dead rising from the grave, human sacrifice and 40 years of darkness, all of these things are real. However, the ability to turn these macro concerns into an intelligent -- and profitable -- investment thesis has eluded humanity for as long as I can remember. Look no further than the macro-trading hedge funds that have done so poorly in recent months. Macro funds are the very vehicles that are supposed to a) anticipate, b) position in front of, and c) profit off of these big macro events. Only they haven’t been able to do so. Despite a strong start to the year, storied names have all suffered significant setbacks. For example,  Fortress, with $66 billion in assets, had big loss that forced out several executives. A macro hedge fund managed by the GLG unit of the Man Group is closing.  Harness took a big hit as well, and investors pulled $4.2 billion out of hedge fund giant Brevan Howard. Much of these losses were due to the Swiss National Bank's decision to end a peg for the national currency, the franc -- and nobody saw it coming. Not to read too much into this, but these results look like a telling sign as to the success of the funds' investment models. No one ever knows the future, but humans harbor this illusion that they have a sense of what is happening, some idea of what will occur, and an ability to control their fates as events unfold. The Gods find these qualities quirky and amusing, always worth a chuckle on Mount Olympus. Back on terra firma the recent surprises combine to chip away at the lies humans tell themselves to get through their day. Each unexpected result reveals in a small way how much the previously believed clarity was only a mirage. Eventually, the accumulation of truth startles its recipients with its unwanted message: No one knows nuthin'. Don't misunderstand or dismiss my criticism as arrogance or hubris; my single greatest strength isn't that I am smarter than everyone else, or a better trader, but rather, that I am willing to admit how little I know. Despite the rhetoric from pundits and the rising noise levels, investors have the same options they have always had: First, you can take a guess when the bull market will end. You can listen to the self-promoters, pundits and other charlatans seeking the limelight, none of whom have a clue about what the future holds or have the slightest interest in your financial well-being. Or, you can make a long-term plan and stick to it. Just remember, the trading gods are watching. And they find you hilarious. This column does not necessarily reflect the opinion of Bloomberg View's editorial board or Bloomberg LP, its owners and investors. To contact the author on this story: Barry L Ritholtz at britholtz3@bloomberg.net To contact the editor on this story: James Greiff at jgreiff@bloomberg.net


News Article | July 22, 2015
Site: www.prweb.com

A longtime provider of commercial vehicle and trucking insurance products, GLG Insurance Professionals is proud to announce that it is currently providing bobtail insurance that is tailored to the specific needs of your single vehicle or fleet. The company is located in Las Vegas, Nevada. Some of the commercial vehicles the company provides insurance for includes semi-trucks, regional carriers, moving trucks, flatbed trucks, pickup trucks, long-haul vehicles, commercial buses, dump trucks, garbage trucks, tankers, refrigerated vans, dry vans, and freight forwarders. Bobtail insurance is known by a number of different names, including deadhead, contingent liability, and bobhead insurance. No matter which name is used to refer to this type of insurance, the coverage that it provides is specifically designed for those times when you are not actively hauling or your tractor is not attached to your trailer and you are involved in an accident. It's designed to protect your financial interests when you are driving toward a terminal to pick up a trailer, driving away from a location without your trailer, or driving you are in between freight. "We understand the importance of keeping our customers protected against the costs arising from vehicle mishaps, which is why we want to offer affordable bobtail insurance that can protect their vehicles even if they aren't actively in use for hauling purposes," stated one of the original representatives of the company. "We encourage all truckers to find out whether or not their vehicle is covered by bobtail insurance. Employers don't always provide this type of insurance, so it is important to ask." Commercial truck drivers who are interested in learning more about bobtail insurance for their commercial vehicles are invited to visit the company's website at glgins.com/. Alternatively, they can call the office during normal business hours at 702.360.2111 to speak with one of our representatives. A prominent provider of insurance coverage located in the Las Vegas area, GLG Insurance Professionals provides a comprehensive selection of products for personal and business purposes, including the provision of bobtail, long haul trucking and specialty commercial vehicle insurance policies. The staff at GLG Insurance assists customers wanting a more personalized experience when comparing available insurance options, easing the process of selecting insurance products. GLG's website offers informative content on its current selection of commercial insurance products. Interested parties can request a free quote for an insurance product tailored to their particular needs.

Loading GLG Inc collaborators
Loading GLG Inc collaborators